Brovana

Active Ingredient(s): Arformoterol Tartrate
FDA Approved: * October 6, 2006
Pharm Company: * SEPRACOR
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Brovana Overview

Arformoterol is a long-acting β2 adrenoreceptor agonist (LABA) indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion, under the trade name Brovana, as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization.[1] It is the active (R,R)-(−)-enantiomer of formoterol and was approved by the United States Food and Drug Administration (FDA) on October 6, 2006 for the treatment of...

Read more Brovana Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Arformoterol

Recent Brovana Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Arformoterol Tartrate
  • Solution: 0.015mg/2ml, 15mcg(base)/2ml, 15mcg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Brovana: (1 result)

Sorted by National Drug Code
  • 63402-911 Brovana 15 ug/2ml Respiratory (Inhalation) Solution by Sunovion Pharmaceuticals Inc.

Other drugs which contain Arformoterol Tartrate or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA